{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:32:06Z","timestamp":1790627526574,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1420-9","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T15:46:48Z","timestamp":1549640808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo"],"prefix":"10.1186","volume":"16","author":[{"given":"Brian","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Neely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Kallianpur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"1420_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343:938\u201352.","journal-title":"N Engl J Med"},{"key":"1420_CR2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/jcp.2005.031195","volume":"59","author":"S Love","year":"2006","unstructured":"Love S. Demyelinating diseases. J Clin Pathol. 2006;59:1151\u20139.","journal-title":"J Clin Pathol"},{"key":"1420_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01037","volume":"419","author":"A Kumanogoh","year":"2002","unstructured":"Kumanogoh A, Marukawa S, Suzuki K, Takegahara N, Watanabe C. Ch\u2019ng E, et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature. 2002;419:629\u201333.","journal-title":"Nature"},{"key":"1420_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1759091415587502","volume":"7","author":"DF Leitner","year":"2015","unstructured":"Leitner DF, Todorich B, Zhang X, Connor JR. Semaphorin4A is cytotoxic to oligodendrocytes and is elevated in microglia and multiple sclerosis. ASN Neuro. 2015;7:1\u201313.","journal-title":"ASN Neuro"},{"key":"1420_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/glia.23313","volume":"66","author":"B Chiou","year":"2018","unstructured":"Chiou B, Lucassen E, Sather M, Kallianpur A, Connor J. Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: a novel neuro-immune axis. Glia. 2018;66:1317\u201330.","journal-title":"Glia."},{"key":"1420_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2013.12.014","volume":"268","author":"T Koda","year":"2014","unstructured":"Koda T, Okuno T, Takata K, Honorat JA, Kinoshita M, Tada S, et al. Sema4A inhibits the therapeutic effect of IFN-\u03b2 in EAE. J Neuroimmunol. 2014;268:43\u20139.","journal-title":"J Neuroimmunol"},{"key":"1420_CR7","first-page":"115","volume":"16","author":"K Yukawa","year":"2005","unstructured":"Yukawa K, Tanaka T, Bai T, Ueyama T, Owada-Makabe K, Tsubota Y, et al. Semaphorin 4A induces growth cone collapse of hippocampal neurons in a Rho\/Rho-kinase-dependent manner. Int J Mol Med. 2005;16:115\u20138.","journal-title":"Int J Mol Med"},{"key":"1420_CR8","first-page":"227","volume":"17","author":"L Wang","year":"2015","unstructured":"Wang L, Song G, Zheng Y, Tan W, Pan J, Zhao Y, et al. Expression of Semaphorin 4A and its potential role in rheumatoid arthritis. Arthritis Res. Ther. BioMed Central. 2015;17:227.","journal-title":"BioMed Central"},{"key":"1420_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.intimp.2013.08.005","volume":"17","author":"G Mogie","year":"2013","unstructured":"Mogie G, Shanks K, Nkyimbeng-Takwi E, Smith E, Davila E, Lipsky M, et al. Neuroimmune semaphorin 4A as a drug and drug target for asthma. Int Immunopharmacol. 2013;17:568\u201375.","journal-title":"Int Immunopharmacol"},{"key":"1420_CR10","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.4049\/jimmunol.1102023","volume":"188","author":"Y Nakatsuji","year":"2012","unstructured":"Nakatsuji Y, Okuno T, Moriya M, Sugimoto T, Kinoshita M, Takamatsu H, et al. Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-\u03b2 therapy in multiple sclerosis. J Immunol. 2012;188:4858\u201365.","journal-title":"J Immunol"},{"key":"1420_CR11","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/sj.emboj.7601589","volume":"26","author":"T Toyofuku","year":"2007","unstructured":"Toyofuku T, Yabuki M, Kamei J, Kamei M, Makino N, Kumanogoh A, et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J. 2007;26:1373\u201384.","journal-title":"EMBO J"},{"key":"1420_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cellimm.2013.03.006","volume":"281","author":"GE Linder","year":"2013","unstructured":"Linder GE, Chuntova PD, McLelland BT, A\u00f1\u00f3 L, Obodo UC, Crider NJ, et al. Semaphorin 4A is dynamically regulated during thymocyte development in mice. Cell Immunol. 2013;281:150\u20138.","journal-title":"Cell Immunol"},{"key":"1420_CR13","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1471-4159.2008.05678.x","volume":"107","author":"B Todorich","year":"2008","unstructured":"Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem. 2008;107:1495\u2013505.","journal-title":"J Neurochem"},{"key":"1420_CR14","unstructured":"Chiou B, Neal EH, Bowman AB, Lippmann ES, Simpson IA, Connor JR. Endothelial cells are critical regulators of iron transport in a model of the human blood\u2013brain barrier. J Cereb Blood Flow Metab. 2018:0271678X1878337. \n                    https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29911470\n                    \n                  ."},{"key":"1420_CR15","doi-asserted-by":"publisher","first-page":"e0198775","DOI":"10.1371\/journal.pone.0198775","volume":"13","author":"B Chiou","year":"2018","unstructured":"Chiou B, Neal EH, Bowman AB, Lippmann ES, Simpson IA, Connor JR. Pharmaceutical iron formulations do not cross a model of the human blood-brain barrier. Deli MA, editor. PLoS One. 2018;13:e0198775.","journal-title":"PLoS One"},{"key":"1420_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/brainsci6030023","volume":"6","author":"H Liu","year":"2016","unstructured":"Liu H, Xu E, Liu J, Xiong H. Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders. Brain Sci. Multidisciplinary Digital Publishing Institute (MDPI). 2016;6:23.","journal-title":"Brain Sci"},{"key":"1420_CR17","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75:2087\u201396.","journal-title":"Neurology"},{"key":"1420_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3\u201316.","journal-title":"J Neurovirol"},{"key":"1420_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s13365-011-0032-7","volume":"17","author":"TL Jernigan","year":"2011","unstructured":"Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, et al. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011;17:248\u201357.","journal-title":"J Neurovirol"},{"key":"1420_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s13365-013-0185-7","volume":"19","author":"C Fennema-Notestine","year":"2013","unstructured":"Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre SL, Notestine RJ, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol Justin McArthur Mary Smith. 2013;19:393\u2013401.","journal-title":"J Neurovirol"},{"key":"1420_CR21","doi-asserted-by":"publisher","first-page":"e0193986","DOI":"10.1371\/journal.pone.0193986","volume":"13","author":"T Koda","year":"2018","unstructured":"Koda T, Namba A, Nakatsuji Y, Niino M, Miyazaki Y, Sugimoto T, et al. Beneficial effects of fingolimod in MS patients with high serum Sema4A levels. Suzumura A, editor. PLoS One. 2018;13:e0193986.","journal-title":"PLoS One"},{"key":"1420_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/brain\/awr012","volume":"134","author":"JR Connor","year":"2011","unstructured":"Connor JR, Ponnuru P, Wang X-S, Patton SM, Allen RP, Earley CJ, et al. Profile of altered brain iron acquisition in restless legs syndrome. Brain. 2011;134:959\u201368.","journal-title":"Brain"},{"key":"1420_CR23","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.bbadis.2014.09.016","volume":"1842","author":"W Nandar","year":"2014","unstructured":"Nandar W, Neely EB, Simmons Z, Connor JR. H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis. Biochim Biophys Acta - Mol Basis Dis Elsevier B.V. 2014;1842:2413\u201326.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"1420_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41467-018-03128-9","volume":"9","author":"N Lu","year":"2018","unstructured":"Lu N, Li Y, Zhang Z, Xing J, Sun Y, Yao S, et al. Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4. Nat Commun. 2018;9:742.","journal-title":"Nat Commun."},{"key":"1420_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbrc.2010.10.029","volume":"402","author":"H Ishii","year":"2010","unstructured":"Ishii H, Kubo T, Kumanogoh A, Yamashita T. Th1 cells promote neurite outgrowth from cortical neurons via a mechanism dependent on semaphorins. Biochem Biophys Res Commun. 2010;402:168\u201372.","journal-title":"Biochem Biophys Res Commun"},{"key":"1420_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41586-018-0360-3","volume":"560","author":"Z Hubler","year":"2018","unstructured":"Hubler Z, Allimuthu D, Bederman I, Elitt MS, Madhavan M, Allan KC, et al. Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination. Nature. 2018;560:372\u20136.","journal-title":"Nature"},{"key":"1420_CR27","doi-asserted-by":"crossref","unstructured":"Mangale V, McIntyre LL, Walsh CM, Loring JF, Lane TE. Promoting remyelination through cell transplantation therapies in a model of viral-induced neurodegenerative disease. Dev Dyn. 2018;248(1):43\u201352.","DOI":"10.1002\/dvdy.24658"},{"key":"1420_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12026-010-8201-y","volume":"50","author":"E Nkyimbeng-Takwi","year":"2011","unstructured":"Nkyimbeng-Takwi E, Chapoval SP. Biology and function of neuroimmune semaphorins 4A and 4D. Immunol Res. 2011;50:10\u201321.","journal-title":"Immunol Res"},{"key":"1420_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ijpara.2015.07.003","volume":"45","author":"DF Leitner","year":"2015","unstructured":"Leitner DF, Stoute JA, Landmesser M, Neely E, Connor JR. The HFE genotype and a formulated diet controlling for iron status attenuate experimental cerebral malaria in mice. Int J Parasitol. 2015;45:797\u2013808.","journal-title":"Int J Parasitol"},{"key":"1420_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/acn3.136","volume":"2","author":"AB Ragin","year":"2015","unstructured":"Ragin AB, Wu Y, Gao Y, Keating S, Du H, Sammet C, et al. Brain alterations within the first 100 days of HIV infection. Ann Clin Transl Neurol. 2015;2:12\u201321.","journal-title":"Ann Clin Transl Neurol"},{"key":"1420_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001756-199412300-00040","volume":"6","author":"GM Liuzzi","year":"1994","unstructured":"Liuzzi GM, Mastoianni CM, Fanelli M, Massetti AP, Vullo V, Delia S, et al. Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases. Neuroreport. 1994;6:157\u201360.","journal-title":"Neuroreport"},{"key":"1420_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2741\/1830","volume":"11","author":"L Valle Del","year":"2006","unstructured":"Del Valle L, Pi\u00f1a-Oviedo S. HIV disorders of the brain: pathology and pathogenesis. Front Biosci. 2006;11:718\u201332.","journal-title":"Front Biosci"},{"key":"1420_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/13550280902769756","volume":"15","author":"A Gongvatana","year":"2009","unstructured":"Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, et al. White matter tract injury and cognitive impairment in human immunodeficiency virus\u2013infected individuals. J Neurovirol. 2009;15:187\u201395.","journal-title":"J Neurovirol"},{"key":"1420_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s13365-017-0524-1","volume":"23","author":"LA Cysique","year":"2017","unstructured":"Cysique LA, Soares JR, Geng G, Scarpetta M, Moffat K, Green M, et al. White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration. J Neurovirol. 2017;23:539\u201347.","journal-title":"J Neurovirol"},{"key":"1420_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jnnp-2014-307932","volume":"86","author":"J Gold","year":"2015","unstructured":"Gold J, Goldacre R, Maruszak H, Giovannoni G, Yeates D, Goldacre M. HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J Neurol Neurosurg Psychiatry. 2015;86:9\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1420_CR36","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1242\/jcs.00674","volume":"116","author":"A Kumanogoh","year":"2003","unstructured":"Kumanogoh A, Kikutani H. Immune semaphorins: a new area of semaphorin research. J Cell Sci. 2003;116:3463\u201370.","journal-title":"J Cell Sci"},{"key":"1420_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/intimm\/dxh224","volume":"17","author":"I Chabbert-de Ponnat","year":"2005","unstructured":"Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, Thomasset N, et al. Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int Immunol. 2005;17:439\u201347.","journal-title":"Int Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1420-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1420-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1420-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T19:08:22Z","timestamp":1581102502000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1420-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1420"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1420-9","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Pennsylvania State University College of Medicine Institutional Animal Care and Use Committee, protocol 47464. Human CSF tissue were obtained from HIV+ adults who were previously recruited to the multicenter HIV Neurobehavioral Research Center (HNRC) at the University of California, San Diego. HIV+ study participants provided written informed consent for lumbar puncture, medical records review, and comprehensive neuropsychiatric testing.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"28"}}